PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2011 | 46 |
| 2012 | 84 |
| 2013 | 100 |
| 2014 | 91 |
| 2015 | 98 |
| 2016 | 79 |
| 2017 | 86 |
| 2018 | 81 |
| 2019 | 80 |
| 2020 | 119 |
| 2021 | 127 |
| 2022 | 117 |
| 2023 | 114 |
| 2024 | 115 |
| 2025 | 116 |
| 2026 | 79 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Cancer Discov"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Dual Functions of B7-H3-MAPK Signaling Orchestrate Tumor Immunosuppression via Regulating the Plasticity of Myeloid-derived Suppressor Cells and Fibroblasts.
- Shi W, Xu P, Gu Q, Fan Z, Liang X, Wang Y, Zhao Y, Meng C, Leo J, Kim JJ, Teng H, Zhang J, Chen F, Chen Y, Navin NE, Zhao D.
- Cancer Discov. Author manuscript. 2026 Sep 18:10.1158/2159-8290.CD-25-1613. doi: 10.1158/2159-8290.CD-25-1613. Online ahead of print.
- PMCID: PMC13652009
Shi W, et al.Cancer Discov. Author manuscript. 2026.PMCID: PMC13652009 -
Asynchronous Evolution of Epithelium and Stroma Differentiates Precursor Lesions from Pancreatic Cancer.
- Elhossiny AM, Kadiyala P, Okoye JO, Hiraki HL, Procario MC, Giridharan T, Watkoske HR, Tannus Ruckert M, Wang J, Griffith BD, Bray AW, Mills JN, Espinoza CE, Zeller J, Peterson N, Bednar F, Zhang Y, Rao A, Lyssiotis CA, Szczepanski JM, Shi J, Deshpande A, Maitra A, Fertig EJ, Carpenter ES, Frankel TL, Pasca di Magliano M.
- Cancer Discov. 2026 Oct 1;16(10):2060-2084. doi: 10.1158/2159-8290.CD-25-2001.
- PMCID: PMC13628107
Elhossiny AM, et al.Cancer Discov. 2026.PMCID: PMC13628107 -
Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis.
- Chen Z, Ren X, Zhang Y, Kang Y, Yang Y, Xu Y, Zhou Q, Liao C, Zeng Q, Liu X, Lin R, Yang Y, Luo F, Shen S, Peng S, Li X, Long J, Xu L, Kuang M.
- Cancer Discov. 2026 Oct 1;16(10):2130-2150. doi: 10.1158/2159-8290.CD-25-0820.
- PMCID: PMC13628106
Chen Z, et al.Cancer Discov. 2026.PMCID: PMC13628106 -
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune Architecture.
- Yu K, Chen J, Chu YY, Nair S, Crupi E, Hasanov E, Mei Y, Han X, Liu Y, Liu Y, Pei G, Peng F, Liao J, Dai E, Chu T, Cho KS, Jiang J, Yan X, Dai Y, Wang J, Zhang B, Genovese G, Putluri N, Eberlin L, Yang L, Lin C, Kwong LN, Shamsutdinova D, Wani KM, Czerniak BA, Yu W, Zhao J, Guo CC, Hansel D, Pettaway C, Pisters L, Bree K, Navai N, Lee BH, Kamat AM, Sharma P, Corn P, Jiang CY, Shah AY, Alhalabi O, Msaouel P, Siefker-Radtke AO, Logothetis CJ, Campbell MT, Lazar AJ, Gao J, Wang L.
- Cancer Discov. 2026 Oct 1;16(10):2037-2059. doi: 10.1158/2159-8290.CD-26-0099.
- PMCID: PMC13628100
Yu K, et al.Cancer Discov. 2026.PMCID: PMC13628100 -
Mismatch Repair-Proficient Colorectal Cancer Can Evade Immune Surveillance through an Intrinsic Suppressive Program.
- Cattaneo CM, Scardellato S, Mauri G, Matafora V, Ojala VK, Cannariato C, Chilà R, Magnani ZI, Scheper W, Lazzari L, Voest EE, Bonini MC, Bachi A, Siena S, Marsoni S, Germano G, Bardelli A.
- Cancer Discov. 2026 Oct 1;16(10):1992-2007. doi: 10.1158/2159-8290.CD-26-0542.
- PMCID: PMC13628094
Cattaneo CM, et al.Cancer Discov. 2026.PMCID: PMC13628094 -
Follicular Lymphoma Transformation is Characterized by Cytokine-associated Remodeling of Stromal and Macrophage Compartments.
- Haradhvala NJ, Yiu SPT, Beckmann L, Sadigh S, Leibowitz Z, Landolsi E, Rivero S, Deng SL, Hu S, Zhang M, Filip D, Pospistle A, Yeo YY, Maurer K, Gustafsson J, Stewart K, Shanmugam V, Van Orden M, Lu WS, Li S, Livak KJ, Qiu H, Basak A, Shalek AK, Danysh BP, McDonough M, Gohil SH, Ren Y, Zhou Y, Neuberg DS, Tyekucheva S, Rodig SJ, Jacobsen ED, Mraz M, Murakami MA, Kurt H, Wu CJ, Getz G, Jiang S, Parry EM.
- Cancer Discov. Author manuscript. 2026 Aug 4:10.1158/2159-8290.CD-25-1104. doi: 10.1158/2159-8290.CD-25-1104. Online ahead of print.
- PMCID: PMC13552640
Haradhvala NJ, et al.Cancer Discov. Author manuscript. 2026.PMCID: PMC13552640 -
Implementing Mutational Epidemiology on a Global Scale: Lessons from Mutographs.
- Stratton MR, Humphreys L, Alexandrov LB, Balmain A, Brennan P, Campbell PJ, Phillips DH.
- Cancer Discov. Author manuscript. 2025 Jan 13;15(1):22-27. doi: 10.1158/2159-8290.CD-24-1687.
- PMCID: PMC13539406
Stratton MR, et al.Cancer Discov. Author manuscript. 2025.PMCID: PMC13539406 -
The Evolution of Polyclonal Competition in Aging Hematopoiesis.
- Mon Père NV, Terenzi F, Werner B.
- Cancer Discov. 2026 Sep 1;16(9):1765-1779. doi: 10.1158/2159-8290.CD-25-0990.
- PMCID: PMC13531000
Mon Père NV, et al.Cancer Discov. 2026.PMCID: PMC13531000 -
Intratumoral Sotigalimab with Pembrolizumab Induces Rapid Activation of Antigen-Presenting Cells and Drives Antitumor Responses in Non-injected Tumors in Metastatic Melanoma: A Phase I/II Study.
- Bentebibel SE, McGrail DJ, Kochat V, Arslan E, Abdel-Wahab R, Pazdrak B, Murthy R, Tahon NHM, Cho SN, Duose DY, Wani KM, Liu J, Haymaker C, Gomez JA, Sonnemann H, Katailiha AS, Nassif-Rausseo B, Rahim M, Li I, Mayer AT, Yang X, Hsu FJ, Zhang J, Johnson DH, Amaria RN, Glitza Oliva IC, Patel SP, Hwu P, Elsayes KM, Tawbi HA, Burks JK, Bernatchez C, Davies MA, Rai K, Lizée G, Ekmekcioglu S, Diab A.
- Cancer Discov. 2026 Sep 1;16(9):1780-1800. doi: 10.1158/2159-8290.CD-25-1551.
- PMCID: PMC13530994
Bentebibel SE, et al.Cancer Discov. 2026.PMCID: PMC13530994 -
TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers.
- Nicholson HE, Whittington DA, Bruzzese FJ, Lazarides K, Martires LCM, Tonini MR, Jenkins HN, Zhang M, Shahagadkar P, Pratt CB, Briggs KJ, McCarren P, Tsai AW, Bandi M, Min C, Huang A, Zhang H, Meier SR, Shen B, Yu Y, Liang C, Liu Y, Teng T, Zhang J, Crystal A, Mallender WD, Wu XE, Maxwell JP, Andersen JN.
- Cancer Discov. 2026 Sep 1;16(9):1884-1902. doi: 10.1158/2159-8290.CD-26-0040.
- PMCID: PMC13531002
Nicholson HE, et al.Cancer Discov. 2026.PMCID: PMC13531002